Data as of Aug 26
| +0.56 / +0.34%|
The 14 analysts offering 12-month price forecasts for Allergan Inc have a median target of 200.00, with a high estimate of 240.00 and a low estimate of 174.00. The median estimate represents a +21.97% increase from the last price of 163.97.
The current consensus among 20 polled investment analysts is to Buy stock in Allergan Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.